New Ways to Protect the Host from SARS-CoV-2? Lung Microbiome Metabolites Inhibit STAT3 and Modulate the

Jency Roshni1, Mahema Sivakumar1, Faris Ahmed Bahammam2

  • 1Drug Discovery and Multi-omics Lab, Faculty of Allied Health Sciences, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Kelambakkam, Tamil Nadu, India.

Insights

Lung microbiome metabolites impact the COVID-19 immune response. Thymidine diphosphate showed high affinity with STAT3, suggesting new therapeutic targets for COVID-19 treatment.

Area of Science:

  • Systems biology and immunology
  • Microbiome research
  • Infectious disease

Background:

  • COVID-19 is a systemic disease affecting multiple organs and pathways.
  • Lung microbiota dysbiosis is observed in COVID-19 patients, but its role is unclear.
  • A systems biology approach is needed to understand COVID-19's complexity.

Purpose of the Study:

  • To investigate the impact of lung microbiome metabolites on the host immune system during COVID-19.
  • To identify key regulators of the host immune response in bronchial and alveolar cells.

Main Methods:

  • RNA sequencing (RNAseq) to identify differentially expressed genes (DEGs) in response to SARS-CoV-2.
  • Construction of an immune network using overlapping DEGs from bronchial and alveolar cells.
  • Computational analysis including molecular docking and molecular dynamics to assess metabolite-protein interactions.

Main Results:

  • Identified 68 overlapping DEGs, with Signal Transducer and Activator of Transcription 3 (STAT3) regulating most.
  • Lung microbiome-derived thymidine diphosphate exhibited higher binding affinity to STAT3 than known inhibitors.
  • Molecular dynamics revealed significant changes in the STAT3 complex behavior upon binding.

Conclusions:

  • Lung microbiome metabolites play a crucial role in modulating the host immune system during COVID-19.
  • Thymidine diphosphate emerges as a potential modulator of STAT3 activity in COVID-19.
  • Findings suggest novel avenues for preventive medicine and therapeutic innovation targeting the lung microbiome.

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
86
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
51
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.5K